Management empresarial acquires $2.96 million in PBF Vitality shares

3 months ago

Management Empresarial de Capitales S.A. de C.V., a big shareholder of PBF Vitality Inc. (NYSE:PBF), has just lately elevated its…

Evolent Well being's SWOT evaluation: healthcare tech inventory faces challenges amid progress

3 months ago

Evolent Well being's SWOT evaluation: healthcare tech inventory faces challenges amid progress

Wall St slips with blended information and earnings forward of Fed week

3 months ago

By Sinéad Carew and Johann M Cherian (Reuters) - Wall Avenue's most important indexes closed decrease on Friday as buyers…

Have fuel costs peaked for 2025?

3 months ago

Investing.com -- U.S. pure fuel costs have surged in early 2025, with spot Henry Hub up roughly 12% year-to-date and the…

Lightbridge CFO Larry Goldman sells $299,614 in inventory

3 months ago

Larry Goldman, the Chief Monetary Officer of Lightbridge Corp (NASDAQ:LTBR), just lately executed a number of inventory transactions as reported…

Lululemon’s SWOT evaluation: athletic attire large faces product challenges

3 months ago

Lululemon Athletica Inc. (NASDAQ:LULU), a number one designer and retailer of athletic attire with a market capitalization of $47.3 billion,…

Moody’s revises Kenya’s rankings to ‘constructive’ on potential liquidity dangers easing

3 months ago

(Reuters) - International rankings company Moody's (NYSE:MCO) revised Kenya's outlook to "constructive" from "unfavourable" on Friday, citing a possible ease…

Blackstone to purchase $1 billion Virginia energy plant close to information facilities

3 months ago

By David French (Reuters) -The unit of Blackstone (NYSE:BX) devoted to investments within the vitality business has agreed to accumulate…

Lightbridge EVP Andrey Mushakov sells $404,088 in inventory

3 months ago

Along with these gross sales, Mushakov exercised choices to amass 10,070 shares at a value of $3.82 per share, amounting…

Genmab’s SWOT evaluation: biotech agency’s inventory faces development and integration challenges

3 months ago

Genmab (NASDAQ:GMAB), a biotechnology firm with a market capitalization of $16.91 billion specializing in most cancers therapies, notably a number…